Cutia Therapeutics (2487.HK)
2487.HK Stock Price Chart
Explore Cutia Therapeutics interactive price chart. Choose custom timeframes to analyze 2487.HK price movements and trends.
2487.HK Company Profile
Discover essential business fundamentals and corporate details for Cutia Therapeutics (2487.HK) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
12 Jun 2023
Employees
333.00
Website
https://www.cutiatx.comCEO
Lele Zhang
Description
Cutia Therapeutics operates as a biopharmaceutical company that develops a dermatology platform for skin and scalp diseases. The company focuses on the dermatology treatment and care therapeutic areas, including localized adipose accumulation management medication, scalp diseases and care, skin diseases and care, and topical anesthesia. The company was incorporated in 2019 and is based in Shanghai, China with additional offices in Beijing, Wuxi and Hong Kong.
2487.HK Financial Timeline
Browse a chronological timeline of Cutia Therapeutics corporate events including earnings releases, dividend announcements, and stock splits.
Earnings released on 23 Mar 2025
EPS came in at -$0.42 , while revenue for the quarter reached $101.83M .
Earnings released on 31 Dec 2024
EPS came in at -$0.40 , while revenue for the quarter reached $97.89M .
Earnings released on 29 Aug 2024
EPS came in at -$0.36 , while revenue for the quarter reached $51.70M .
Earnings released on 30 Jun 2024
EPS came in at -$0.35 , while revenue for the quarter reached $51.32M .
Earnings released on 27 Mar 2024
EPS came in at -$0.57 , while revenue for the quarter reached $55.39M .
Earnings released on 31 Dec 2023
EPS came in at -$0.59 , while revenue for the quarter reached $57.16M .
Earnings released on 29 Aug 2023
EPS came in at -$9.04 , while revenue for the quarter reached $19.60M .
Earnings released on 30 Jun 2023
EPS came in at -$8.56 , while revenue for the quarter reached $18.57M .
Earnings released on 31 Dec 2022
EPS came in at -$2.16 , while revenue for the quarter reached $6.10M .
Earnings released on 30 Sept 2022
EPS came in at -$2.09 , while revenue for the quarter reached $5.88M .
2487.HK Stock Performance
Access detailed 2487.HK performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.